APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preclinical Pharmacokinetics Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Preclinical Pharmacokinetics Services Industry Growth and Trends Forecast to 2032

5 March 2026111 pages

Choose your research edition.

Industry ResearchPreclinical Pharmacokinetics Services Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Preclinical Pharmacokinetics Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Preclinical Pharmacokinetics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preclinical Pharmacokinetics Services Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Preclinical Pharmacokinetics Services Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

According to APO Research, the global Preclinical Pharmacokinetics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Preclinical Pharmacokinetics Services market include Porsolt, Altasciences, Biocytogen, Charles River Laboratories, WuXi AppTec, PyschoGenics, Evotec (Cyprotex), QPS and Aurigene Pharmaceutical Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Preclinical Pharmacokinetics Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Preclinical Pharmacokinetics Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Preclinical Pharmacokinetics Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Preclinical Pharmacokinetics Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Preclinical Pharmacokinetics Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Preclinical Pharmacokinetics Services Market by Company

Porsolt

Altasciences

Biocytogen

Charles River Laboratories

WuXi AppTec

PyschoGenics

Evotec (Cyprotex)

QPS

Aurigene Pharmaceutical Services

Frontage Laboratories

Dalriada

Sygnature Discovery

Admescope

Imavita

IQVIA Laboratories

Pharmaron

Preclinical Pharmacokinetics Services Segment by Type

LC-MS/MS-Based Preclinical Pharmacokinetics Service

Immunoassay-Based Preclinical Pharmacokinetics Service

Others

Preclinical Pharmacokinetics Services Segment by Application

Innovative Small Molecule Drugs

Biopharmaceuticals

Traditional Chinese Medicine & Natural Products

Others

Preclinical Pharmacokinetics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preclinical Pharmacokinetics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preclinical Pharmacokinetics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preclinical Pharmacokinetics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Preclinical Pharmacokinetics Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Preclinical Pharmacokinetics Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Preclinical Pharmacokinetics Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Preclinical Pharmacokinetics Services Market Share by Region (2021-2026) Table 4. Global Preclinical Pharmacokinetics Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Preclinical Pharmacokinetics Services Market Share by Region (2027-2032) Table 6. Global Preclinical Pharmacokinetics Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Preclinical Pharmacokinetics Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Preclinical Pharmacokinetics Services Market Size Share by Type (2021-2026) Table 9. Global Preclinical Pharmacokinetics Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Preclinical Pharmacokinetics Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Preclinical Pharmacokinetics Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Preclinical Pharmacokinetics Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Preclinical Pharmacokinetics Services Market Size Share by Application (2021-2026) Table 24. Global Preclinical Pharmacokinetics Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Preclinical Pharmacokinetics Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Preclinical Pharmacokinetics Services Industry Trends Table 37. Preclinical Pharmacokinetics Services Industry Drivers Table 38. Preclinical Pharmacokinetics Services Industry Opportunities and Challenges Table 39. Preclinical Pharmacokinetics Services Industry Restraints Table 40. Global Preclinical Pharmacokinetics Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Preclinical Pharmacokinetics Services Revenue Market Share by Company (2021-2026) Table 42. Global Preclinical Pharmacokinetics Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Preclinical Pharmacokinetics Services Key Company Headquarters & Area Served Table 44. Global Preclinical Pharmacokinetics Services Company, Product Type & Application Table 45. Global Preclinical Pharmacokinetics Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Preclinical Pharmacokinetics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Porsolt Company Information Table 49. Porsolt Business Overview Table 50. Porsolt Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Porsolt Preclinical Pharmacokinetics Services Product Portfolio Table 52. Porsolt Recent Development Table 53. Altasciences Company Information Table 54. Altasciences Business Overview Table 55. Altasciences Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Altasciences Preclinical Pharmacokinetics Services Product Portfolio Table 57. Altasciences Recent Development Table 58. Biocytogen Company Information Table 59. Biocytogen Business Overview Table 60. Biocytogen Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Biocytogen Preclinical Pharmacokinetics Services Product Portfolio Table 62. Biocytogen Recent Development Table 63. Charles River Laboratories Company Information Table 64. Charles River Laboratories Business Overview Table 65. Charles River Laboratories Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Charles River Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 67. Charles River Laboratories Recent Development Table 68. WuXi AppTec Company Information Table 69. WuXi AppTec Business Overview Table 70. WuXi AppTec Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. WuXi AppTec Preclinical Pharmacokinetics Services Product Portfolio Table 72. WuXi AppTec Recent Development Table 73. PyschoGenics Company Information Table 74. PyschoGenics Business Overview Table 75. PyschoGenics Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. PyschoGenics Preclinical Pharmacokinetics Services Product Portfolio Table 77. PyschoGenics Recent Development Table 78. Evotec (Cyprotex) Company Information Table 79. Evotec (Cyprotex) Business Overview Table 80. Evotec (Cyprotex) Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Evotec (Cyprotex) Preclinical Pharmacokinetics Services Product Portfolio Table 82. Evotec (Cyprotex) Recent Development Table 83. QPS Company Information Table 84. QPS Business Overview Table 85. QPS Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. QPS Preclinical Pharmacokinetics Services Product Portfolio Table 87. QPS Recent Development Table 88. Aurigene Pharmaceutical Services Company Information Table 89. Aurigene Pharmaceutical Services Business Overview Table 90. Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Product Portfolio Table 92. Aurigene Pharmaceutical Services Recent Development Table 93. Frontage Laboratories Company Information Table 94. Frontage Laboratories Business Overview Table 95. Frontage Laboratories Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Frontage Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 97. Frontage Laboratories Recent Development Table 98. Dalriada Company Information Table 99. Dalriada Business Overview Table 100. Dalriada Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Dalriada Preclinical Pharmacokinetics Services Product Portfolio Table 102. Dalriada Recent Development Table 103. Sygnature Discovery Company Information Table 104. Sygnature Discovery Business Overview Table 105. Sygnature Discovery Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sygnature Discovery Preclinical Pharmacokinetics Services Product Portfolio Table 107. Sygnature Discovery Recent Development Table 108. Admescope Company Information Table 109. Admescope Business Overview Table 110. Admescope Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Admescope Preclinical Pharmacokinetics Services Product Portfolio Table 112. Admescope Recent Development Table 113. Imavita Company Information Table 114. Imavita Business Overview Table 115. Imavita Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Imavita Preclinical Pharmacokinetics Services Product Portfolio Table 117. Imavita Recent Development Table 118. IQVIA Laboratories Company Information Table 119. IQVIA Laboratories Business Overview Table 120. IQVIA Laboratories Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. IQVIA Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 122. IQVIA Laboratories Recent Development Table 123. Pharmaron Company Information Table 124. Pharmaron Business Overview Table 125. Pharmaron Preclinical Pharmacokinetics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Pharmaron Preclinical Pharmacokinetics Services Product Portfolio Table 127. Pharmaron Recent Development Table 128. North America Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Preclinical Pharmacokinetics Services Market Share by Country (2021-2026) Table 131. North America Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Preclinical Pharmacokinetics Services Market Share Forecast by Country (2027-2032) Table 133. Europe Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Preclinical Pharmacokinetics Services Market Share by Country (2021-2026) Table 136. Europe Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Preclinical Pharmacokinetics Services Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Preclinical Pharmacokinetics Services Market Share by Country (2021-2026) Table 141. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Preclinical Pharmacokinetics Services Market Share Forecast by Country (2027-2032) Table 143. Latin America Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Preclinical Pharmacokinetics Services Market Share by Country (2021-2026) Table 146. Latin America Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Preclinical Pharmacokinetics Services Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Country (2021-2026) Table 151. Middle East & Africa Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Preclinical Pharmacokinetics Services Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Preclinical Pharmacokinetics Services Product Image Figure 3. Global Preclinical Pharmacokinetics Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Preclinical Pharmacokinetics Services Market Share by Region: 2025 VS 2032 Figure 6. Global Preclinical Pharmacokinetics Services Market Share by Region (2021-2032) Figure 7. North America Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. LC-MS/MS-Based Preclinical Pharmacokinetics Service Image Figure 13. Global LC-MS/MS-Based Preclinical Pharmacokinetics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Immunoassay-Based Preclinical Pharmacokinetics Service Image Figure 15. Global Immunoassay-Based Preclinical Pharmacokinetics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Preclinical Pharmacokinetics Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Preclinical Pharmacokinetics Services Market Share by Type 2025 VS 2032 Figure 20. North America Preclinical Pharmacokinetics Services Market Size Share by Type (2021-2032) Figure 21. Europe Preclinical Pharmacokinetics Services Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Share by Type (2021-2032) Figure 23. Latin America Preclinical Pharmacokinetics Services Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Preclinical Pharmacokinetics Services Market Size Share by Type (2021-2032) Figure 25. Innovative Small Molecule Drugs Image Figure 26. Global Innovative Small Molecule Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Biopharmaceuticals Image Figure 28. Global Biopharmaceuticals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Traditional Chinese Medicine & Natural Products Image Figure 30. Global Traditional Chinese Medicine & Natural Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Preclinical Pharmacokinetics Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Preclinical Pharmacokinetics Services Market Share by Application 2025 VS 2032 Figure 35. North America Preclinical Pharmacokinetics Services Market Size Share by Application (2021-2032) Figure 36. Europe Preclinical Pharmacokinetics Services Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Preclinical Pharmacokinetics Services Market Size Share by Application (2021-2032) Figure 38. Latin America Preclinical Pharmacokinetics Services Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Preclinical Pharmacokinetics Services Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Preclinical Pharmacokinetics Services Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Preclinical Pharmacokinetics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Preclinical Pharmacokinetics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 45. Europe Preclinical Pharmacokinetics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Preclinical Pharmacokinetics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 48. Asia-Pacific Preclinical Pharmacokinetics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Preclinical Pharmacokinetics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 51. Latin America Preclinical Pharmacokinetics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Preclinical Pharmacokinetics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 54. Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • LC-MS/MS-Based Preclinical Pharmacokinetics Service
  • Immunoassay-Based Preclinical Pharmacokinetics Service
  • Others
Applications
  • Innovative Small Molecule Drugs
  • Biopharmaceuticals
  • Traditional Chinese Medicine & Natural Products
  • Others
Companies covered
  • Porsolt
  • Altasciences
  • Biocytogen
  • Charles River Laboratories
  • WuXi AppTec
  • PyschoGenics
  • Evotec (Cyprotex)
  • QPS
  • Aurigene Pharmaceutical Services
  • Frontage Laboratories
  • Dalriada
  • Sygnature Discovery
  • Admescope
  • Imavita
  • IQVIA Laboratories
  • Pharmaron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Preclinical Pharmacokinetics Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Preclinical Pharmacokinetics Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Preclinical Pharmacokinetics Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Preclinical Pharmacokinetics Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Preclinical Pharmacokinetics Services Market Size (2021-2032)
  8. 1.5.1 North America Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Preclinical Pharmacokinetics Services Market Size Growth Rate (2021-2032)
2 Preclinical Pharmacokinetics Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 LC-MS/MS-Based Preclinical Pharmacokinetics Service
  3. 2.1.2 Immunoassay-Based Preclinical Pharmacokinetics Service
  4. 2.1.3 Others
  5. 2.2 Global Preclinical Pharmacokinetics Services Market Size by Type
  6. 2.2.1 Global Preclinical Pharmacokinetics Services Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Preclinical Pharmacokinetics Services Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Preclinical Pharmacokinetics Services Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Preclinical Pharmacokinetics Services Market Size by Regions
  10. 2.3.1 North America Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Preclinical Pharmacokinetics Services Market Size Breakdown by Type (2021-2026)
3 Preclinical Pharmacokinetics Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Innovative Small Molecule Drugs
  3. 3.1.2 Biopharmaceuticals
  4. 3.1.3 Traditional Chinese Medicine & Natural Products
  5. 3.1.4 Others
  6. 3.2 Global Preclinical Pharmacokinetics Services Market Size by Application
  7. 3.2.1 Global Preclinical Pharmacokinetics Services Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Preclinical Pharmacokinetics Services Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Preclinical Pharmacokinetics Services Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Preclinical Pharmacokinetics Services Market Size by Regions
  11. 3.3.1 North America Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Preclinical Pharmacokinetics Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Preclinical Pharmacokinetics Services Industry Trends
  2. 4.2 Preclinical Pharmacokinetics Services Industry Drivers
  3. 4.3 Preclinical Pharmacokinetics Services Industry Opportunities and Challenges
  4. 4.4 Preclinical Pharmacokinetics Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Preclinical Pharmacokinetics Services Revenue (2021-2026)
  2. 5.2 Global Preclinical Pharmacokinetics Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Preclinical Pharmacokinetics Services Key Company Headquarters & Area Served
  4. 5.4 Global Preclinical Pharmacokinetics Services Company, Product Type & Application
  5. 5.5 Global Preclinical Pharmacokinetics Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Preclinical Pharmacokinetics Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Preclinical Pharmacokinetics Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Preclinical Pharmacokinetics Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Porsolt
  2. 6.1.1 Porsolt Company Information
  3. 6.1.2 Porsolt Business Overview
  4. 6.1.3 Porsolt Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Porsolt Preclinical Pharmacokinetics Services Product Portfolio
  6. 6.1.5 Porsolt Recent Developments
  7. 6.2 Altasciences
  8. 6.2.1 Altasciences Company Information
  9. 6.2.2 Altasciences Business Overview
  10. 6.2.3 Altasciences Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Altasciences Preclinical Pharmacokinetics Services Product Portfolio
  12. 6.2.5 Altasciences Recent Developments
  13. 6.3 Biocytogen
  14. 6.3.1 Biocytogen Company Information
  15. 6.3.2 Biocytogen Business Overview
  16. 6.3.3 Biocytogen Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Biocytogen Preclinical Pharmacokinetics Services Product Portfolio
  18. 6.3.5 Biocytogen Recent Developments
  19. 6.4 Charles River Laboratories
  20. 6.4.1 Charles River Laboratories Company Information
  21. 6.4.2 Charles River Laboratories Business Overview
  22. 6.4.3 Charles River Laboratories Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Charles River Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  24. 6.4.5 Charles River Laboratories Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 WuXi AppTec Preclinical Pharmacokinetics Services Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 PyschoGenics
  32. 6.6.1 PyschoGenics Company Information
  33. 6.6.2 PyschoGenics Business Overview
  34. 6.6.3 PyschoGenics Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 PyschoGenics Preclinical Pharmacokinetics Services Product Portfolio
  36. 6.6.5 PyschoGenics Recent Developments
  37. 6.7 Evotec (Cyprotex)
  38. 6.7.1 Evotec (Cyprotex) Company Information
  39. 6.7.2 Evotec (Cyprotex) Business Overview
  40. 6.7.3 Evotec (Cyprotex) Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Evotec (Cyprotex) Preclinical Pharmacokinetics Services Product Portfolio
  42. 6.7.5 Evotec (Cyprotex) Recent Developments
  43. 6.8 QPS
  44. 6.8.1 QPS Company Information
  45. 6.8.2 QPS Business Overview
  46. 6.8.3 QPS Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 QPS Preclinical Pharmacokinetics Services Product Portfolio
  48. 6.8.5 QPS Recent Developments
  49. 6.9 Aurigene Pharmaceutical Services
  50. 6.9.1 Aurigene Pharmaceutical Services Company Information
  51. 6.9.2 Aurigene Pharmaceutical Services Business Overview
  52. 6.9.3 Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Product Portfolio
  54. 6.9.5 Aurigene Pharmaceutical Services Recent Developments
  55. 6.10 Frontage Laboratories
  56. 6.10.1 Frontage Laboratories Company Information
  57. 6.10.2 Frontage Laboratories Business Overview
  58. 6.10.3 Frontage Laboratories Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Frontage Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  60. 6.10.5 Frontage Laboratories Recent Developments
  61. 6.11 Dalriada
  62. 6.11.1 Dalriada Company Information
  63. 6.11.2 Dalriada Business Overview
  64. 6.11.3 Dalriada Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Dalriada Preclinical Pharmacokinetics Services Product Portfolio
  66. 6.11.5 Dalriada Recent Developments
  67. 6.12 Sygnature Discovery
  68. 6.12.1 Sygnature Discovery Company Information
  69. 6.12.2 Sygnature Discovery Business Overview
  70. 6.12.3 Sygnature Discovery Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sygnature Discovery Preclinical Pharmacokinetics Services Product Portfolio
  72. 6.12.5 Sygnature Discovery Recent Developments
  73. 6.13 Admescope
  74. 6.13.1 Admescope Company Information
  75. 6.13.2 Admescope Business Overview
  76. 6.13.3 Admescope Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Admescope Preclinical Pharmacokinetics Services Product Portfolio
  78. 6.13.5 Admescope Recent Developments
  79. 6.14 Imavita
  80. 6.14.1 Imavita Company Information
  81. 6.14.2 Imavita Business Overview
  82. 6.14.3 Imavita Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Imavita Preclinical Pharmacokinetics Services Product Portfolio
  84. 6.14.5 Imavita Recent Developments
  85. 6.15 IQVIA Laboratories
  86. 6.15.1 IQVIA Laboratories Company Information
  87. 6.15.2 IQVIA Laboratories Business Overview
  88. 6.15.3 IQVIA Laboratories Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 IQVIA Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  90. 6.15.5 IQVIA Laboratories Recent Developments
  91. 6.16 Pharmaron
  92. 6.16.1 Pharmaron Company Information
  93. 6.16.2 Pharmaron Business Overview
  94. 6.16.3 Pharmaron Preclinical Pharmacokinetics Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Pharmaron Preclinical Pharmacokinetics Services Product Portfolio
  96. 6.16.5 Pharmaron Recent Developments
7 North America
  1. 7.1 North America Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  3. 7.3 North America Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  3. 8.3 Europe Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  3. 10.3 South America Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Preclinical Pharmacokinetics Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst